Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 3:27 pm Purchase | 2025-03-31 | 13G | FibroGen, Inc. FGEN | ARMISTICE CAPITAL LLC | 340,000 8.420% | 68,000 (+25.00%) | Filing History |
| 2025-05-15 3:27 pm Sale | 2025-03-31 | 13G | Enlivex Therapeutics Ltd. ENLV | ARMISTICE CAPITAL LLC | 1,781,931 7.530% | -426,069 (-19.30%) | Filing History |
| 2025-05-15 3:27 pm Purchase | 2025-03-31 | 13G | Processa Pharmaceuticals, Inc. PCSA | ARMISTICE CAPITAL LLC | 578,605 9.990% | 578,605 (New Position) | Filing History |
| 2025-05-15 3:27 pm Purchase | 2025-03-31 | 13G | Ekso Bionics Holdings, Inc. EKSO | ARMISTICE CAPITAL LLC | 13,319 9.990% | 3,319 (+33.19%) | Filing History |
| 2025-05-15 3:26 pm Purchase | 2025-03-31 | 13G | Dermata Therapeutics, Inc. DRMA | ARMISTICE CAPITAL LLC | 1,065,076 9.990% | 788,654 (+285.31%) | Filing History |
| 2025-05-15 3:25 pm Sale | 2025-03-31 | 13G | DANIMER SCIENTIFIC INC DNMRQ | ARMISTICE CAPITAL LLC | 89,999 9.990% | -81,762 (-47.60%) | Filing History |
| 2025-05-15 3:25 pm Sale | 2025-03-31 | 13G | ALTAMIRA THERAPEUTICS LTD SHS CYTOF | ARMISTICE CAPITAL LLC | 473,870 9.990% | -4,677 (-0.98%) | Filing History |
| 2025-05-15 3:24 pm Purchase | 2025-03-31 | 13G | Oxbridge Re Holdings Limited OXBR | ARMISTICE CAPITAL LLC | 622,165 8.360% | 622,165 (New Position) | Filing History |
| 2025-05-15 3:24 pm Purchase | 2025-03-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | ARMISTICE CAPITAL LLC | 1,656,315 9.200% | 1,600,202 (+2851.75%) | Filing History |
| 2025-05-15 3:23 pm Sale | 2025-03-31 | 13G | Cosmos Health Inc. COSM | ARMISTICE CAPITAL LLC | 1,917,710 7.030% | -590,303 (-23.54%) | Filing History |
| 2025-05-15 3:23 pm Sale | 2025-03-31 | 13G | Wearable Devices Ltd. WLDS | ARMISTICE CAPITAL LLC | 73,342 9.990% | -18,247 (-19.92%) | Filing History |
| 2025-05-15 3:23 pm Sale | 2025-03-31 | 13G | ACCELERATE DIAGNOSTICS INC AXDXQ | ARMISTICE CAPITAL LLC | 1,879,227 7.450% | -198,773 (-9.57%) | Filing History |
| 2025-05-15 3:22 pm Purchase | 2025-03-31 | 13G | Voyager Therapeutics, Inc. VYGR | ARMISTICE CAPITAL LLC | 5,436,000 9.850% | 40,000 (+0.74%) | Filing History |
| 2025-05-15 3:22 pm Unchanged | 2025-03-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS | ARMISTICE CAPITAL LLC | 5,096,251 11.430% | 0 (Unchanged) | Filing History |
| 2025-05-15 3:22 pm Purchase | 2025-03-31 | 13G | Sphere 3D Corp. ANY | ARMISTICE CAPITAL LLC | 2,660,745 9.990% | 77,027 (+2.98%) | Filing History |
| 2025-05-15 3:21 pm Purchase | 2025-03-31 | 13G | Catheter Precision, Inc. VTAK | ARMISTICE CAPITAL LLC | 1,000,849 9.990% | 126,770 (+14.50%) | Filing History |
| 2025-05-15 3:21 pm Purchase | 2025-03-31 | 13G | MacKenzie Realty Capital, Inc. MKZR | ARMISTICE CAPITAL LLC | 1,579,006 9.990% | 1,579,006 (New Position) | Filing History |
| 2025-05-15 3:20 pm Purchase | 2025-03-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | ARMISTICE CAPITAL LLC | 923,557 9.990% | 10,075 (+1.10%) | Filing History |
| 2025-05-15 3:20 pm Purchase | 2025-03-31 | 13G | Medicus Pharma Ltd. Common Stock MDCX | ARMISTICE CAPITAL LLC | 1,266,000 9.430% | 1,266,000 (New Position) | Filing History |
| 2025-05-15 3:20 pm Purchase | 2025-03-31 | 13G | LI-CYCLE HLDGS CORP COM LICYQ | ARMISTICE CAPITAL LLC | 4,567,108 9.990% | 4,567,108 (New Position) | Filing History |